Comparative study of nifekalant versus amiodarone for shock-resistant ventricular fibrillation in out-of-hospital cardiopulmonary arrest patients.

MLA

Amino, Mari, et al. “Comparative Study of Nifekalant versus Amiodarone for Shock-Resistant Ventricular Fibrillation in out-of-Hospital Cardiopulmonary Arrest Patients.” Journal of Cardiovascular Pharmacology, vol. 55, no. 4, Apr. 2010, pp. 391–98. EBSCOhost, https://doi.org/10.1097/FJC.0b013e3181d3dcc7.

APA

Amino, M., Yoshioka, K., Opthof, T., Morita, S., Uemura, S., Tamura, K., Fukushima, T., Higami, S., Otsuka, H., Akieda, K., Shima, M., Fujibayashi, D., Hashida, T., Inokuchi, S., Kodama, I., & Tanabe, T. (2010). Comparative study of nifekalant versus amiodarone for shock-resistant ventricular fibrillation in out-of-hospital cardiopulmonary arrest patients. Journal of Cardiovascular Pharmacology, 55(4), 391–398. https://doi.org/10.1097/FJC.0b013e3181d3dcc7

Chicago

Amino, Mari, Koichiro Yoshioka, Tobias Opthof, Seiji Morita, Shunryo Uemura, Kozo Tamura, Tomokazu Fukushima, et al. 2010. “Comparative Study of Nifekalant versus Amiodarone for Shock-Resistant Ventricular Fibrillation in out-of-Hospital Cardiopulmonary Arrest Patients.” Journal of Cardiovascular Pharmacology 55 (4): 391–98. doi:10.1097/FJC.0b013e3181d3dcc7.